Back to Search
Start Over
CXCR4 mutational status does not impact outcomes in patients with Waldenström macroglobulinemia treated with proteasome inhibitors.
- Source :
- American Journal of Hematology; Apr2020, Vol. 95 Issue 4, pE95-E98, 4p
- Publication Year :
- 2020
Details
- Language :
- English
- ISSN :
- 03618609
- Volume :
- 95
- Issue :
- 4
- Database :
- Complementary Index
- Journal :
- American Journal of Hematology
- Publication Type :
- Academic Journal
- Accession number :
- 142710077
- Full Text :
- https://doi.org/10.1002/ajh.25730